Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01233388 · ClinicalTrials.gov registry record
Real-time Influenza Vaccine Surveillance
A clinical trial of Vaccine Safety, sponsored by Columbia University.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01233388 is a study of Vaccine Safety that has completed, run by Columbia University. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01233388, a study of Vaccine Safety, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this proposal is to pioneer the implementation and evaluation of a novel patient centered text messaging vaccine adverse event surveillance network.
Conditions Studied
Interventions
- OTHER Text message surveillance
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01233388
The ClinicalTrials.gov registry entry for NCT01233388 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaccine Safety appearing as the primary indexed condition, and to 1 intervention - of which Text message surveillance is the first listed.
NCT01233388 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01233388 about?
NCT01233388 is a clinical study titled "Real-time Influenza Vaccine Surveillance". The aim of this proposal is to pioneer the implementation and evaluation of a novel patient centered text messaging vaccine adverse event surveillance network.
What is the current status of trial NCT01233388?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2010-11. Estimated completion is 2012-05.
What conditions does trial NCT01233388 study?
This clinical trial studies the following conditions: Vaccine Safety.
What interventions are being tested in trial NCT01233388?
The interventions under investigation include: Text message surveillance (OTHER).
Who is sponsoring clinical trial NCT01233388?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01233388 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.